Diabetes mellitus in a domesticated Spanish Mustang

Journal of the American Veterinary Medical Association

Volumn 226, Issue 4, 2005, Pages 584-588

  Johnson, Philip J ^a   Scotty, Nicole C ^a,b   Wiedmeyer, Charles ^a   Messer, Nat T ^a   Kreeger, John M ^a,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; C PEPTIDE; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIOTHYRONINE; METFORMIN; SERUM GLOBULIN; THYROXINE; TRIACYLGLYCEROL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; FIBRINOGEN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HORSE; HORSE DISEASE; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PHYSICAL EXAMINATION; POLYDIPSIA; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; THYROXINE BLOOD LEVEL; URINALYSIS; WEIGHT REDUCTION;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLYBURIDE; HORSE DISEASES; HORSES; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; METFORMIN; TREATMENT OUTCOME;

ANIMALIA; EQUUS CABALLUS;

EID: 13744258781     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.584     Document Type: Article

References (34)

1. Henneke DR, Potter GD, Kreider JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
2. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278.
3. 1c) in screening for undiagnosed diabetes in the US population. Diabetes Care 2000;23:187-191.
4. Wiedmeyer CE, Johnson PJ, Cohn LA, et al. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc 2003;223:987-992.
5. Garcia MC, Beech J. Equine intravenous glucose tolerance test: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 1986;47:570-572.
6. De La Corte FD, Valberg SJ, MacLeay JM, et al. Glucose uptake in horses with polysaccharide storage myopathy. Am J Vet Res 1999;60:458-462.
7. Jorgenson GE. Interesting case of pancreatic glycosurea. J Am Vet Med Assoc 1921;58:718-719.
8. Jeffrey JR. Diabetes mellitus secondary to chronic pancreatitis in a pony. J Am Vet Med Assoc 1968;153:1168-1175.
9. Bulgin MS, Anderson BC. Verminous arteritis and pancreatic necrosis with diabetes mellitus in a pony. Compend Contin Educ Pract Vet 1983;5:S482-S485.
10. McCoy DJ. Diabetes mellitus associated with bilateral granulosa cell tumors in a mare. J Am Vet Med Assoc 1986;188:733-735.
11. Ruoff WW, Baker DC, Morgan SJ, et al. Type II diabetes mellitus in a horse. Equine Vet J 1986;18:143-144.
12. King JM, Kavanaugh JF, Bentinck-Smith J. Diabetes mellitus with pituitary neoplasms in a horse and dog. Cornell Vet 1962;52:133-145
13. Tasker JB, Whiteman CE, Martin BR. Diabetes mellitus in the horse. J Am Vet Med Assoc 1966;149:393-399.
14. Baker JR, Ritchie HE. Diabetes mellitus in the horse: a case report and review of the literature. Equine Vet J 1974;6:7-11.
15. Loeb WF, Capen CC, Johnson LE. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses. Cornell Vet 1966;56:623-639.
16. Muylle E, Van den Hende C, Deprez P, et al. Non-insulin dependent diabetes mellitus in a horse. Equine Vet J 1986;18:145-146.
17. Johnson PJ. Equine metabolic syndrome ("peripheral Cushing's syndrome"). Vet Clin North Am Equine Pract 2002;18:271-293.
18. Schott HC. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am Equine Pract 2002;18:237-270.
19. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962;14:353-362.
20. Chaldakov GN, Stankulov IS, Hristova M, et al. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003;9:1023-1031.
21. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 2003;100:14211-14216.
22. Waleed A, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diabetes Rep 2003;3:293-298.
23. Masuzaki H, Flier JS. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)-a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:255-262.
24. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
25. Permana PA, Del Parigi A, Tataranni PA. Microarray gene expression profiling in obesity and insulin resistance. Nutrition 2004;20:134-138.
26. Dostou J, Gerich J. Pathogenesis of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2001;(suppl 2):149-156.
27. Dailey GE. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes. Expert Opin Pharmacother 2003;4:1417-1430.
28. Giannarelli R, Aragona M, Coppelli A, et al. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab 2003;29:6S28-6S35.
29. Kumar N, Kaul CL, Ishrath A, et al. Combination of metformin and thiazolidindiones restore insulin signaling in insulin-resistant cultured myotubes. Life Sci 2004;74:1877-1888.
30. Ku SK, Lee HS, Park KD, et al. An immunohistochemical study on the pancreatic islets cells of the Mongolian gerbil, Meriones unguiculatus. J Vet Sci 2001;2:9-14.
31. Yukawa M, Takeuchi T, Watanabe T, et al. Proportions of various endocrine cells in the pancreatic islets of wood mice (Apodemus speciosus). Anat Histol Embryol 1999;28:13-16.
32. Wahren J, Ekberg K, Johansson J, et al. Role of C-peptide in human physiology. Am J Pirysiol Endocrinol Metab 2000;278:E759-E768.
33. Torn C. C-peptide and autoimmune markers in diabetes. Clin Lab 2003;49:1-10.
34. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998;54:758-764.